Trial intelligence / Profile preview

Pantoprazole for stress ulcer prophylaxis in ICU (REVISE Pilot)

NCT02290327Phase 3Completed

Sponsor
McMaster University
Start
May 2015
Primary completion
Jan 2016
Modality
Small Molecules
Countries
3
01

Overview

Phase 3, randomised, double-blind trial in gastrointestinal bleeding comparing Pantoprazole with Placebo (2 arms). Primary endpoints: Consent Rate at 12 months, Recruitment Rate at 12 months and 1 more. Started May 2015; status: completed.

02

Drugs

pantoprazole
03

Conditions

gastrointestinal bleeding

Beyond the preview

Go deeper on NCT02290327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02290327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call